EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024

Jiahui Qi iD, Hongwei Li iD, Hao Li, Zhuyuan Wang, Shuo Zhang, Xiangying Meng, Xin Zhao iD, Enwu Yuan iD, Linlin Zhang iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.03121-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jiahui Qi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, COVID-19, Pneumonia, Mycoplasma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies characterizing the epidemic of Mycoplasma pneumoniae ( M. pneumoniae ) in Henan Province are scarce. Our research investigated the epidemiological changes of M. pneumoniae and macrolide-resistant mutations of M. pneumonia e (MRMP) among children under 18 years from January 2017 to December 2024. The study was categorized into three stages based on the COVID-19 timeline (pre-pandemic, pandemic, and post-pandemic) to analyze the impact of nonpharmaceutical interventions (NPIs) on M. pneumoniae in Henan Province. Among 27,056 children, 28.36% tested positive for M. pneumoniae , with the lowest positivity rate in 2022 (12.56%) and the highest in 2023 (35.01%). The positivity rate was greatest in the 6–17 years (41.08%) and lowest in ≤1 year (12.38%). Epidemic seasons were predominantly in autumn (36.71%) and winter (23.12%). The MRMP rate increased from 36.68% in 2018 to 87.16% in 2023, averaging 71.00%. The positivity rate of M. pneumoniae was 26.12% during the pre-pandemic stage, significantly declined during the pandemic stage (14.97%), and rebounded to a high level in the post-pandemic stage (31.88%). The MRMP rate also increased across the three stages: 46.74%, 72.63%, and 83.31%, respectively. These results indicate a significant influence of COVID-19 NPIs on the transmission of M. pneumoniae and MRMP. IMPORTANCE M. pneumoniae is a significant cause of community-acquired pneumonia with a high MRMP rate in China. Various NPIs in the COVID-19 pandemic have impacted the prevalence of M. pneumoniae and could have important implications for M. pneumoniae prevention and control strategies. Our study documented M. pneumoniae and MRMP detection before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024, aiming to investigate the impact of NPIs on M. pneumoniae transmission and continue to monitor the evolution of the epidemiological characteristics of M. pneumoniae infection after the pandemic when restrictive measures are no longer needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma pneumoniaeCOVID-19Pneumonia, MycoplasmaHumansChinaChildChild, PreschoolAdolescentInfantFemaleMaleSARS-CoV-2SeasonsMacrolidesAnti-Bacterial AgentsDrug Resistance, BacterialPandemics

Stichwörter der Autor:innen

COVID-19Mycoplasma pneumoniaechildrenmacrolide-resistant mutations of M. pneumoniaenonpharmaceutical interventions

Substanzen

MacrolidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhengzhou Key Laboratory for In Vitro Diagnosis of Hypertensive Disorders of Pregnancy, Zhengzhou, Henan, China.
  • Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, China.

ORCID-Profile: Jiahui Qi, Hongwei Li, Xin Zhao, Enwu Yuan, Linlin Zhang

Zitieren

APA

Qi, J., Li, H., Li, H., Wang, Z., Zhang, S., Meng, X., Zhao, X., Yuan, E., & Zhang, L. (2025). Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03121-24

Vancouver

Qi J, Li H, Li H, Wang Z, Zhang S, Meng X, et al. Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03121-24

BibTeX
@article{Qi2025,
  author = {Qi, Jiahui and Li, Hongwei and Li, Hao and Wang, Zhuyuan and Zhang, Shuo and Meng, Xiangying and Zhao, Xin and Yuan, Enwu and Zhang, Linlin},
  title = {Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.03121-24}
}
Kostenlos starten →